Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CANT1 pseudogene 1 (CANT1P1) is a human pseudogene related to the functional gene CANT1, which encodes the enzyme calcium-activated nucleotidase 1. Pseudogenes such as CANT1P1 do not code for functional proteins and have no known biological or therapeutic role. They are typically classified as non-coding genetic elements with sequence similarity to protein-coding genes but lacking coding potential due to mutations, insertions, or deletions[9]. As such, CANT1P1 is not considered a druggable or therapeutic target, and there is no evidence it is involved in disease pathology, drug interactions, or used as a biomarker. If you are seeking information on the functional protein/gene, you should refer to "Calcium-activated nucleotidase 1 (CANT1)", which encodes a calcium-dependent nucleotidase with roles in proteoglycan synthesis and has been implicated in various human diseases, but CANT1P1 itself is a non-functional pseudogene[1][2][5][6][7][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CANT1 pseudogene 1 (CANT1P1).